论文部分内容阅读
目的为临床救治MRSA感染合并急性肾损害(AKI)患者进行持续肾脏替代治疗(CRRT)时提供抗感染用药参考。方法通过分析临床药师参与救治某院呼吸内科1例MRSA感染合并AKI患者提供的药学服务,根据患者的病情变化,临床药师结合药物的理化特性,积极查阅相关文献资料,与临床医师共同协商,制定出较优化的药物治疗方案。结果通过临床医师及临床药师的共同努力,最终成功救治了该例MRSA感染合并AKI患者。结论临床药师通过收集循证药学证据和患者的实际情况,参与用药方案的设计及调整来开展药学服务,有助于提高该类患者的治疗效果。
Objective To provide a reference for anti-infective treatment in clinical treatment of patients with MRSA infection complicated with acute kidney injury (AKI) undergoing continuous renal replacement therapy (CRRT). Methods According to the changes of the patients and the physical and chemical characteristics of clinical pharmacists combined with the physical and chemical properties of the drugs, one clinical trial of MRSA infection and AKI patients was involved in the rescue and treatment of clinical pharmacists in the Respiratory Medicine of a hospital. The medical practitioners were actively consulted with relevant literatures and consulted with clinicians A more optimized drug treatment programs. Results Through the joint efforts of clinicians and clinical pharmacists, the patients with MRSA infection and AKI were finally successfully treated. Conclusion Clinical pharmacists can help to improve the therapeutic effect of these patients by collecting evidence of evidence-based pharmacy and the actual situation of patients, participating in the design and adjustment of drug regimens.